Literature DB >> 21122648

Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.

George S Abela1.   

Abstract

The response to arterial wall injury is an inflammatory process, which over time becomes integral to the development of atherosclerosis and subsequent plaque instability. However, the underlying injurious agent, critical to this process, has not received much attention. In this review, a model of plaque rupture is hypothesized with two stages of inflammatory activity. In stage I (cholesterol crystal-induced cell injury and apoptosis), intracellular cholesterol crystals induce foam cell apoptosis, setting up a vicious cycle by signaling more macrophages, resulting in accumulation of extra cellular lipids. This local inflammation eventually leads to the formation of a semi-liquid, lipid-rich necrotic core of a vulnerable plaque. In stage II (cholesterol crystal-induced arterial wall injury), the saturated lipid core is now primed for crystallization, which can manifest as a clinical syndrome with a systemic inflammation response. Cholesterol crystallization is the trigger that causes core expansion, leading to intimal injury. We recently demonstrated that when cholesterol crystallizes from a liquid to a solid state, it undergoes volume expansion, which can tear the plaque cap. This observation of cholesterol crystals perforating the cap and intimal surface was made in the plaques of patients who died with acute coronary syndrome. We have also demonstrated that several agents (ie, statins, aspirin, and ethanol) can dissolve cholesterol crystals and may be exerting their immediate benefits by this direct mechanism. Also, because recent studies have demonstrated that high-sensitivity C-reactive protein may be a reliable marker in selecting patients for statin therapy, it could reflect the presence of intimal injury by cholesterol crystals. This was demonstrated in an atherosclerotic rabbit model. Therefore, we propose that cholesterol crystallization could help explain in part both local and systemic inflammation associated with atherosclerosis.
Copyright © 2010 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21122648     DOI: 10.1016/j.jacl.2010.03.003

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  46 in total

1.  The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals.

Authors:  Claudine E Pang; Jeffrey D Messinger; Emma C Zanzottera; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2015-08-19       Impact factor: 12.079

2.  Label-free quantitative imaging of cholesterol in intact tissues by hyperspectral stimulated Raman scattering microscopy.

Authors:  Ping Wang; Junjie Li; Pu Wang; Chun-Rui Hu; Delong Zhang; Michael Sturek; Ji-Xin Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-14       Impact factor: 15.336

3.  Chemically Specific Imaging Through Stimulated Raman Photoexcitation and Ultrasound Detection: Minireview.

Authors:  Vladislav V Yakovlev; Georgi I Petrov; Hao F Zhang; Gary D Noojin; Patrick A Thomas; Michael L Denton; Benjamin A Rockwell; Robert J Thomas
Journal:  Aust J Chem       Date:  2012-01-01       Impact factor: 1.321

4.  Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging.

Authors:  Ryan S Lim; Jeffrey L Suhalim; Shinobu Miyazaki-Anzai; Makoto Miyazaki; Moshe Levi; Eric O Potma; Bruce J Tromberg
Journal:  J Lipid Res       Date:  2011-09-23       Impact factor: 5.922

Review 5.  Symptomatic and asymptomatic carotid artery plaque.

Authors:  Majid M Mughal; Mohsin K Khan; J Kevin DeMarco; Arshad Majid; Fadi Shamoun; George S Abela
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-10

6.  Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study.

Authors:  Shunichi Nakamura; Shigenobu Inami; Koji Murai; Masamichi Takano; Hitoshi Takano; Kuniya Asai; Masahiro Yasutake; Wataru Shimizu; Kyoichi Mizuno
Journal:  Clin Res Cardiol       Date:  2014-08-03       Impact factor: 5.460

7.  Quantifying progression and regression of thrombotic risk in experimental atherosclerosis.

Authors:  Rohun U Palekar; Andrew P Jallouk; Matthew J Goette; Junjie Chen; Jacob W Myerson; John S Allen; Antonina Akk; Lihua Yang; Yizheng Tu; Mark J Miller; Christine T N Pham; Samuel A Wickline; Hua Pan
Journal:  FASEB J       Date:  2015-04-09       Impact factor: 5.191

8.  Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.

Authors:  Eivind O Samstad; Nathalie Niyonzima; Stig Nymo; Marie H Aune; Liv Ryan; Siril S Bakke; Knut T Lappegård; Ole-Lars Brekke; John D Lambris; Jan K Damås; Eicke Latz; Tom E Mollnes; Terje Espevik
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

9.  IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1.

Authors:  Bijoy Chellan; Ling Yan; Timothy J Sontag; Catherine A Reardon; Marion A Hofmann Bowman
Journal:  J Lipid Res       Date:  2013-12-23       Impact factor: 5.922

Review 10.  Inflammation and atherosclerosis: direct versus indirect mechanisms.

Authors:  Michael E Rosenfeld
Journal:  Curr Opin Pharmacol       Date:  2013-01-26       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.